Overview

Effect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery: A Risk-Stratified Randomized Controlled Trial.

Status:
NOT_YET_RECRUITING
Trial end date:
2026-03-30
Target enrollment:
Participant gender:
Summary
Effect of a 20% Reduction in Hyperbaric Bupivacaine Dose on High Spinal Block Incidence in Cesarean Delivery: A Risk-Stratified Randomized Controlled Trial.
Phase:
PHASE4
Details
Lead Sponsor:
Aswan University